This review explores the potential of methionine restriction as a therapeutic strategy for cancer treatment, particularly for tumors dependent on methionine. It discusses how methionine restriction, either through dietary changes or enzymatic depletion (e.g., methioninase), inhibits tumor cell growth, especially in cancers with methylthioadenosine phosphorylase (MTAP) deficiency. The article also
